These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27471491)

  • 1. Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone.
    Morris EV; Edwards CM
    Front Endocrinol (Lausanne); 2016; 7():90. PubMed ID: 27471491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the host microenvironment to cancer-induced bone disease.
    Olechnowicz SW; Edwards CM
    Cancer Res; 2014 Mar; 74(6):1625-31. PubMed ID: 24599133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte-Cancer Cell Interactions in the Bone Microenvironment.
    Otley MOC; Sinal CJ
    Front Endocrinol (Lausanne); 2022; 13():903925. PubMed ID: 35903271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of bone marrow adipocytes in bone metastasis.
    Morris EV; Edwards CM
    J Bone Oncol; 2016 Sep; 5(3):121-123. PubMed ID: 27761371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow adiposity and multiple myeloma.
    Morris EV; Edwards CM
    Bone; 2019 Jan; 118():42-46. PubMed ID: 29548987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue:Critical contributor to the development of prostate cancer.
    Uehara H; Kobayashi T; Matsumoto M; Watanabe S; Yoneda A; Bando Y
    J Med Invest; 2018; 65(1.2):9-17. PubMed ID: 29593201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose, Bone, and Myeloma: Contributions from the Microenvironment.
    McDonald MM; Fairfield H; Falank C; Reagan MR
    Calcif Tissue Int; 2017 May; 100(5):433-448. PubMed ID: 27343063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
    Soley L; Falank C; Reagan MR
    Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells.
    Falank C; Fairfield H; Reagan MR
    Front Endocrinol (Lausanne); 2016; 7():67. PubMed ID: 27379019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.
    Chkourko Gusky H; Diedrich J; MacDougald OA; Podgorski I
    Obes Rev; 2016 Nov; 17(11):1015-1029. PubMed ID: 27432523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells.
    Herroon MK; Diedrich JD; Podgorski I
    Front Endocrinol (Lausanne); 2016; 7():84. PubMed ID: 27458427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.
    Allegra A; Innao V; Gerace D; Allegra AG; Vaddinelli D; Bianco O; Musolino C
    Eur J Intern Med; 2018 Jul; 53():12-20. PubMed ID: 29859797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis.
    Luo G; He Y; Yu X
    Front Endocrinol (Lausanne); 2018; 9():339. PubMed ID: 30013512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on Cancer in the Bone Marrow: Adverse Roles of Adipocytes.
    Falank C; Fairfield H; Reagan MR
    Curr Mol Biol Rep; 2017 Dec; 3(4):254-262. PubMed ID: 29399440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
    Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
    Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
    Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014; 16(6):484. PubMed ID: 25757219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
    Ye L; Kynaston HG; Jiang WG
    Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.
    Shay G; Tauro M; Loiodice F; Tortorella P; Sullivan DM; Hazlehurst LA; Lynch CC
    Oncotarget; 2017 Jun; 8(26):41827-41840. PubMed ID: 28611279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.